BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 18292655)

  • 1. Multiple eruptive dermatofibromas in a patient receiving efalizumab.
    Santos-Juanes J; Coto-Segura P; Mallo S; Galache C; Soto J
    Dermatology; 2008; 216(4):363. PubMed ID: 18292655
    [No Abstract]   [Full Text] [Related]  

  • 2. Multiple Clustered Dermatofibromas Following Ustekinumab Treatment for
    Ruiz-Villaverde R; Díaz-Martinez MA; Sánchez-Cano D
    Sultan Qaboos Univ Med J; 2017 Aug; 17(3):e375-e377. PubMed ID: 29062570
    [No Abstract]   [Full Text] [Related]  

  • 3. Multiple eruptive dermatofibromas in a patient with dermatomyositis taking prednisolone and methotrexate.
    Huang PY; Chu CY; Hsiao CH
    J Am Acad Dermatol; 2007 Nov; 57(5 Suppl):S81-4. PubMed ID: 17097372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple Eruptive Dermatofibromas in a Patient Treated With Brentuximab Vedotin.
    Giavedoni P; Combalia A; Pigem R; Mascaró JM
    Actas Dermosifiliogr (Engl Ed); 2019 Jun; 110(5):419-420. PubMed ID: 30717880
    [No Abstract]   [Full Text] [Related]  

  • 5. Dermatitis during efalizumab treatment in a patient with psoriasis vulgaris.
    de Groot M; de Rie MA; Bos JD
    Br J Dermatol; 2005 Oct; 153(4):843-4. PubMed ID: 16181475
    [No Abstract]   [Full Text] [Related]  

  • 6. Multiple eruptive dermatofibromas.
    Callahan S; Matires K; Shvartsbeyn M; Brinster N
    Dermatol Online J; 2015 Dec; 21(12):. PubMed ID: 26990339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transitioning patients from efalizumab to alternative psoriasis therapies: findings from an open-label, multicenter, Phase IIIb study.
    Menter A; Hamilton TK; Toth DP; Leung HM; Wetherill G; Hennessey B; Garovoy M; Kwon P; Pariser DM;
    Int J Dermatol; 2007 Jun; 46(6):637-48. PubMed ID: 17550570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple eruptive dermatofibromas aggravated by mycophenolate mofetil and pirfenidone in a patient with systemic sclerosis.
    Wang R; Li G; Nong L; Wang M
    Rheumatology (Oxford); 2020 Dec; 59(12):4000-4001. PubMed ID: 32572469
    [No Abstract]   [Full Text] [Related]  

  • 9. [Final recommendations to incorporate efalizumab into the clinical practice].
    García-Díez A; Ferrándiz C
    Actas Dermosifiliogr; 2008 Jan; 99 Suppl 1():82. PubMed ID: 18341857
    [No Abstract]   [Full Text] [Related]  

  • 10. Perianal Dermatophytosis During Secukinumab Therapy for Plaque Psoriasis.
    Quach OL; Hsu S
    JAMA Dermatol; 2016 Apr; 152(4):486-7. PubMed ID: 26720159
    [No Abstract]   [Full Text] [Related]  

  • 11. Effective management of psoriasis symptom worsening during efalizumab therapy without discontinuing treatment: a case study.
    Gisondi P; Giglio MD; Girolomoni G
    J Dermatolog Treat; 2006; 17(3):172-5. PubMed ID: 16854760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efalizumab-induced aseptic meningitis.
    Kluger N; Girard C; Gonzalez V; Guillot B; Bessis D
    Br J Dermatol; 2007 Jan; 156(1):189-91. PubMed ID: 17199599
    [No Abstract]   [Full Text] [Related]  

  • 13. Ustekinumab (Stelara) for psoriasis.
    Med Lett Drugs Ther; 2010 Jan; 52(1330):7-8. PubMed ID: 20208473
    [No Abstract]   [Full Text] [Related]  

  • 14. Efalizumab for patients with moderate to severe plaque psoriasis: a randomized controlled trial.
    Gordon KB; Papp KA; Hamilton TK; Walicke PA; Dummer W; Li N; Bresnahan BW; Menter A;
    JAMA; 2003 Dec; 290(23):3073-80. PubMed ID: 14679270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efalizumab-induced autoimmune pancytopenia.
    Tom WL; Miller MD; Hurley MY; Suneja T; Kudva G; Leonardi CL; Obadiah JM
    Br J Dermatol; 2006 Nov; 155(5):1045-7. PubMed ID: 17034539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple eruptive myxoid dermatofibromas: report of first case and review of literature.
    Antal A; Zelger B; Reifenberger J; Niehues T; Feyen O; Megahed M; Ruzicka T; Homey B
    Br J Dermatol; 2007 Aug; 157(2):382-5. PubMed ID: 17596172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Palmoplantar pustular psoriasis: successful therapy with efalizumab after non-response to infliximab.
    Wozel G; Vitez L
    Acta Derm Venereol; 2008; 88(2):169-70. PubMed ID: 18311451
    [No Abstract]   [Full Text] [Related]  

  • 18. Eruptive dermatofibromas in a kindred.
    Samlaska C; Bennion S
    Cutis; 2002 Mar; 69(3):187-8, 190. PubMed ID: 11926338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple eruptive dermatofibromas in a patient with primary pulmonary hypertension.
    Lee HW; Lee DK; Oh SH; Choi JC; Lee MW; Choi JH; Moon KC; Koh JK
    Br J Dermatol; 2005 Oct; 153(4):845-7. PubMed ID: 16181476
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum sickness due to infliximab in a patient with psoriasis.
    Krishnan RS; Hsu S
    J Drugs Dermatol; 2004; 3(3):305-8. PubMed ID: 15176166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.